Search results for "Diabetes"
Diabetes, gabapentinoids, and high-value care
This issue covers some clinical dilemmas and offers insights into the value of care.
https://acphospitalist.acponline.org/archives/2019/12/letter-from-the-editor.htm
15 Dec 2019
Research on strokes and readmissions in COVID-19, updated guidance from NIH and SSC
One study showed that strokes were rare in COVID-19 patients, while another didn't find any connection between fever or biomarkers before discharge and readmissions. The NIH and the Surviving Sepsis Campaign (SSC) updated their COVID-19 critical care recommendations.
https://acphospitalist.acponline.org/weekly/archives/2021/02/10/1.htm
10 Feb 2021
September 2012
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2012/09/
October 12, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/10/12/
December issue online and in the mail
The latest issue of ACP Hospitalist covers diabetes, gabapentinoids, high-value care, burnout, and antibiotic stewardship.
https://acphospitalist.acponline.org/weekly/archives/2019/12/11/5.htm
11 Dec 2019
August 24, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/08/24/
May 25, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/05/25/
Medications that can exacerbate heart failure often continued despite heart failure hospitalization
Many heart failure patients were still prescribed albuterol, metformin, or diltiazem at discharge, as well as many other medications on the American Heart Association's list of drugs that can precipitate or induce heart failure.
https://acphospitalist.acponline.org/weekly/archives/2019/11/13/3.htm
13 Nov 2019
Dapagliflozin reduced risk for hospitalization in CKD patients with or without diabetes
A post hoc analysis of an industry-funded trial found that dapagliflozin reduced overall risk of hospitalization as well as risk of hospitalization ending in death in patients with chronic kidney disease (CKD).
https://acphospitalist.acponline.org/archives/2022/12/07/dapagliflozin-reduced-risk-for-hospitalization-in-ckd-patients-with-or-without-diabetes.htm
7 Dec 2022
Recent guidance offered on preparing to treat COVID-19
ACP continues to press the government to do more to address the novel coronavirus disease (COVID-19) and expand coverage of and access to testing and treatment.
https://acphospitalist.acponline.org/weekly/archives/2020/03/18/1.htm
18 Mar 2020